Microarray-based molecular diagnostics: High-throughput identification of bloodborne pathogens for the control and management of disease

总部位于多伦多的安全生物系统公司(SGBio)正在开发一种可重复使用的基于微阵列的分子诊断平台，用于识别血源性致病菌。SGBio独特的分子检测有可能取代目前基于细胞培养的检测标准。他们的方法在诊断的可靠性和效率方面都提供了巨大的优势。SGBio正在寻求合作开发一个生物信息学软件平台，以整合到他们的设备中。该软件将提高其产品的有效性，并简化其产品工作流程的吞吐量。该项目的成功完成将使SGBio能够在未来1-2年内将他们的分子诊断平台推向市场，为HQP提供宝贵的培训，并导致多伦多/密西索加地区的显著研发增长。

The Toronto based company Safeguard Biosystems (SGBio) is developing a reusable microarray-based molecular diagnostic platform for identifying bloodborne pathogenic bacteria. SGBio's unique molecular assay has the potential to replace the current standard of cell-culture based assays. Their approach offers a tremendous advantage in both reliability and efficiency of diagnosis. SGBio is looking to collaborate on the development of a Bioinformatics software platform to incorporate into their device. The software will improve the effectiveness of their product and streamline the throughput of their product workflow. Successful completion of this project will allow SGBio to bring their molecular diagnostic platform to market in the next 1-2 years, provide valuable training to HQP, and lead to significant R&D growth within the Toronto/Mississauga regions.